Lee Hye Young, Hong Sung Jin, Jung In Hyun, Kim Gwang Sil, Byun Young Sup, Kim Byung Ok
Division of Cardiology, Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.
Division of Cardiology, Yonsei University College of Medicine, Seoul, Korea.
Yonsei Med J. 2019 Jun;60(6):535-541. doi: 10.3349/ymj.2019.60.6.535.
Whether cardiac rehabilitation (CR) improves clinical outcomes in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) has not been thoroughly evaluated. Moreover, few studies have sought to identify patients who would benefit most from CR among STEMI patients.
Consecutively, 265 STEMI patients who underwent primary PCI with implantation of DESs and follow-up angiography were examined. Seventy-six patients (30%) who received CR were assigned to the CR+ group. Another 178 patients (70%) who did not participate in CR were assigned to the CR- group. Second generation DESs were implanted in 238 (94%) patients.
Major adverse cardiovascular events (MACEs), including death, myocardial infarction, and revascularization, were compared. The CR+ group tended to have lower MACE than the CR- group at 3 years, although the difference was not statistically significant (9.9% vs. 18.3%, hazard ratio=0.54, =0.138). Subgroup analysis revealed a significant interaction according to CR and preprocedural thrombolysis in myocardial infarction (TIMI) flow ( value for interaction=0.011). In patients with low preprocedural TIMI flow (TIMI flow ≤1, n=161), those in the CR+ group had significantly lower MACE than those in the CR- group (=0.005), whereas MACE was not different among patients with higher TIMI flow (TIMI flow ≥2, n=93).
CR including exercise training was associated with lower MACE, particularly in patients with lower preprocedural TIMI flow during primary PCI for STEMI in the current DES era.
心脏康复(CR)是否能改善接受药物洗脱支架(DES)植入的直接经皮冠状动脉介入治疗(PCI)的ST段抬高型心肌梗死(STEMI)患者的临床结局,尚未得到充分评估。此外,很少有研究试图确定STEMI患者中最能从CR中获益的患者。
连续检查了265例接受DES植入的直接PCI并进行随访血管造影的STEMI患者。76例(30%)接受CR的患者被分配到CR+组。另外178例(70%)未参加CR的患者被分配到CR-组。238例(94%)患者植入了第二代DES。
比较了包括死亡、心肌梗死和血运重建在内的主要不良心血管事件(MACE)。CR+组在3年时的MACE倾向于低于CR-组,尽管差异无统计学意义(9.9%对18.3%,风险比=0.54,P=0.138)。亚组分析显示,根据CR和术前心肌梗死溶栓(TIMI)血流存在显著交互作用(交互作用P值=0.011)。在术前TIMI血流较低(TIMI血流≤1,n=161)的患者中,CR+组的MACE显著低于CR-组(P=0.005),而在TIMI血流较高(TIMI血流≥2,n=93)的患者中,MACE无差异。
在当前DES时代,包括运动训练在内的CR与较低的MACE相关,尤其是在STEMI直接PCI期间术前TIMI血流较低的患者中。